HERE FOR 20 YEARS FOR PEOPLE WITH AN INTEREST IN MULTIPLE SCLEROSIS Skip to content

Data from the UK's COVID-19 extended dosing interval

261 Views 0 Replies

0 Members and 1 Guest are viewing this topic.

Data from the UK's COVID-19 extended dosing interval
on:
#1

From JAMA Network (December 3, 2021)--"Data emerge from the UK's COVID-19 extended dosing interval":


https://bit.ly/3sae1jj
MS Speaks--online for 20 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week)  12/16/20 - 3/16/24.